EUVIMEDEUVIMED entdecken
Fallbericht

EGLN1 mutations in Cis can induce congenital erythrocytosis with thromboses by increasing protein instability

Serge Carillo iD, Marine Delamare, Laurent Henry, Nada Maaziz, Hana Safraou, Betty Gardie, Thierry Lavabre-Bertrand

British Journal of Haematology · 2025

DOI: 10.1111/bjh.19932 ↗

Kurz gefasst

Fallbericht in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Serge Carillo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Cytologie Clinique et Cytogénétique, LBMR néoplasies myéloprolifératives, CHU CAREMEAU, Nîmes, France. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor-Proline Dioxygenases, Mutation, Polycythemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Région des Pays de la Loire, Agence Nationale de la Recherche, Labex GR-Ex.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary congenital erythrocytosis results from constitutive activation of the hypoxia pathway. This pathway is controlled by regulation of the α isoforms of the hypoxia‐inducible factor α/β heterodimer, notably via hydroxylation by prolyl hydroxylase domain 2 (PHD2). Mutations affecting PHD2 are involved in Type 3 erythrocytosis. We report an atypical family bearing two PHD2 mutations located in Cis (L195H and E225D) transmitted in a dominant feature, together with a phenotypic analysis, structural modelling and functional study. Mutations have a cumulative effect, with E255D playing the major role, and severely compromised PHD2 stability, probably explaining why the hypoxia pathway at the origin of the disease is activated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Inducible Factor-Proline DioxygenasesMutationPolycythemiaFemaleHumansMaleModels, MolecularPedigreeProtein Stability

Stichwörter der Autor:innen

EGLN1ECYT3PHD2congenital erythrocytosismolecular diagnosis

Substanzen

EGLN1 protein, humanHypoxia-Inducible Factor-Proline Dioxygenases

Autor:innen und Institutionen

  • Laboratoire de Cytologie Clinique et Cytogénétique, LBMR néoplasies myéloprolifératives, CHU CAREMEAU, Nîmes, France.
  • F15, IBMM UMR5247 CNRS, Université Montpellier, ENSCM, Montpellier, France.
  • Service Histologie, Embryologie et Cytogénétique, UFR Médecine Montpellier-Nîmes, Université de Montpellier, Montpellier, France.
  • Nantes Université, CNRS, INSERM, l'institut du thorax, Nantes, France.
  • Ecole Pratique des Hautes Etudes, EPHE, PSL University, Paris, France.
  • Laboratoire de génétique chromosomique et moléculaire, CHU de Dijon, Dijon, France.

ORCID-Profile: Serge Carillo

Förderung

  • Région des Pays de la Loire
  • Agence Nationale de la Recherche
  • Labex GR-Ex
  • Fonds Européen de Développement Régional
  • VHL Alliance USA
  • VHL France
  • the Génavie association
  • Fondation Maladies Rares

Zitieren

APA

Carillo, S., Delamare, M., Henry, L., Maaziz, N., Safraou, H., Gardie, B., & Lavabre-Bertrand, T. (2025). EGLN1 mutations in Cis can induce congenital erythrocytosis with thromboses by increasing protein instability. British Journal of Haematology. https://doi.org/10.1111/bjh.19932

Vancouver

Carillo S, Delamare M, Henry L, Maaziz N, Safraou H, Gardie B, et al. EGLN1 mutations in Cis can induce congenital erythrocytosis with thromboses by increasing protein instability. British Journal of Haematology. 2025. doi:10.1111/bjh.19932

BibTeX
@article{Carillo2025,
  author = {Carillo, Serge and Delamare, Marine and Henry, Laurent and Maaziz, Nada and Safraou, Hana and Gardie, Betty and Lavabre-Bertrand, Thierry},
  title = {EGLN1 mutations in Cis can induce congenital erythrocytosis with thromboses by increasing protein instability},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.19932}
}
Kostenlos starten →